June 23, 2018 2:45 PM ET


Company Overview of SillaJen Biotherapeutics, Inc.

Company Overview

SillaJen Biotherapeutics, Inc. is a clinical-stage company that focuses on developing and commercializing oncolytic immunotherapy products to treat cancer. The company specializes in the research, development, and manufacture of oncolytic viruses for targeting, attacking, and eradicating cancer. Its product includes Pexa-Vec (pexastimogene devacirepvec), an attenuated (weakened) Wyeth strain vaccinia virus engineered to directly lyse tumor cells and stimulate anti-tumor immunity. SillaJen Biotherapeutics, Inc. was formerly known as Jennerex, Inc. As a result of acquisition of Jennerex, Inc. by SillaJen, Inc., Jennerex, Inc.’s name was changed. The company was incorporated in 2007 and is base...

450 Sansome Street

2nd Floor

San Francisco, CA 94111

United States

Founded in 2007





Key Executives for SillaJen Biotherapeutics, Inc.

Chief Business Officer
Senior Vice President
Age: 57
Chief Medical Officer
Chief Technology Officer
Vice President
Compensation as of Fiscal Year 2017.

SillaJen Biotherapeutics, Inc. Key Developments

SillaJen Biotherapeutics, Inc. Presents at Cambridge Healthtech Institute's 5th Annual Immuno-Oncology Summit, Aug-28-2017 02:30 PM

SillaJen Biotherapeutics, Inc. Presents at Cambridge Healthtech Institute's 5th Annual Immuno-Oncology Summit, Aug-28-2017 02:30 PM. Venue: Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, United States. Speakers: Naomi De Silva, Associate Director, Preclinical Science.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SillaJen Biotherapeutics, Inc., please visit www.sillajenbio.com.php56-21.dfw3-2.websitetestlink.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.